Drug intelligence / Profile preview

apoferritin

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Apoferritin is the iron-free, shell-like protein component of ferritin, consisting of 24 self-assembling subunits that form a hollow nanocage with an outer diameter of approximately 12 nm. In biological systems, it functions as the precursor to ferritin, which stores and releases iron to maintain iron homeostasis and prevent iron-mediated oxidative damage. In pharmaceutical development, apoferritin is primarily utilized as a biocompatible, biodegradable, and non-immunogenic nanoparticle delivery system. Its unique structure allows for the encapsulation of various therapeutic agents, including small molecules (such as doxorubicin or cisplatin) and imaging agents, within its internal cavity. Apoferritin naturally targets the Transferrin Receptor 1 (TfR1/CD71), which is frequently overexpressed in malignant cells and at the blood-brain barrier, facilitating targeted delivery via receptor-mediated endocytosis. Additionally, apoferritin is studied in experimental models of neurodegeneration, such as Parkinson's disease, for its ability to sequester labile iron and inhibit iron-dependent ferroptosis.

Other names
Apo-ferritinhorse spleen apoferritinrecombinant human apoferritin
02

Targets

TFRC (Transferrin Receptor)

Beyond the preview

Go deeper on apoferritin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on apoferritin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call